Cargando…

544. Outpatient Remdesivir Use at a Stand Alone Children's Hospital

BACKGROUND: When remdesivir was approved for non-hospitalized, high-risk patients with mild to moderate COVID-19, Texas Children’s Hospital (TCH) implemented an outpatient clinic for eligible patients to receive remdesivir infusions. There are limited data evaluating the use of outpatient remdesivir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez, Brittany, Stimes, Grant T, Hilliard, Tanya J, Satter, Lisa Forbes, Munoz, Flor M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677536/ http://dx.doi.org/10.1093/ofid/ofad500.613

Ejemplares similares

546. COVID-19 Monoclonal Antibody Use at a Stand Alone Children’s Hospital
por: Stimes, Grant T, et al.
Publicado: (2023)

519. Early Transition to Outpatient Remdesivir Increases Patient Satisfaction while Decreasing Hospital Costs
por: Chesdachai, Supavit, et al.
Publicado: (2023)

550. Effectiveness of Remdesivir for Treatment of COVID-19 in the Outpatient Setting
por: Vo, Vinny P, et al.
Publicado: (2023)

1507. Pharmacodynamic Target Attainment of Daptomycin Against Staphylococcus aureus for Treatment of Pediatric Osteomyelitis
por: Stimes, Grant, et al.
Publicado: (2019)

544. Pharmacokinetic Profile of Ibalizumab From a Phase 3 Trial
por: Kumar, Princy N, et al.
Publicado: (2018)

544. Severe COVID-19 in Children and Young Adults in the Washington DC Metropolitan Region
por: DeBiasi, Roberta L, et al.
Publicado: (2020)

PT544. The effect of acoustic white noise on motor learning and correlation with neural activity in an animal model of ADHD.
por: Eckernäs, Daniel, et al.
Publicado: (2016)

Remdesivir for Outpatient Management: Time to Wait, Not to Act
por: Mohapatra, Prasanta Raghab
Publicado: (2022)

524. Assessing the Safety of an Outpatient Remdesivir Infusion Program for Patients with Severe COVID-19 in the Setting of a Pandemic Surge
por: Gee, Benjamin, et al.
Publicado: (2021)

544. Clonal Spread of Two Sequence Types of Carbapenem-Resistant Acinetobacter baumannii Blood Isolates at a Tertiary Care Hospital in South Korea Over 2.5 Years
por: Eun Kim, Seong, et al.
Publicado: (2019)

Audit for Stand Alone Systems
por: Ferguson, J
Publicado: (1986)

Oxytocin does not stand alone
por: Putnam, Philip T., et al.
Publicado: (2022)

542. Evaluation of Remdesivir to the Outcomes of Hospitalized Patients with COVID-19 Infection in a Tertiary Care Hospital in Southern India
por: Raju, Jomel, et al.
Publicado: (2023)

538. Clinical Evaluation of Drug-drug Interactions with Remdesivir
por: Peng, Chi-Chi, et al.
Publicado: (2023)

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
por: Gottlieb, Robert L., et al.
Publicado: (2021)

544 Clinical Features of Patients with Ataxia-Telangiectasia at Reference Center in Sao Paulo, Brazil
por: Matos, Josemar, et al.
Publicado: (2012)

527. Lower Risk of ICU Admission with Remdesivir in Patients Hospitalized with COVID-19 Pneumonia
por: Lim, Sarah, et al.
Publicado: (2021)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

THE EFFICACY OF REMDESIVIR WITH DEXAMETHASONE VS. DEXAMETHASONE ALONE IN ADULTS HOSPITALIZED WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: AL-MISTAREHI, ABDEL-HAMEED, et al.
Publicado: (2022)

38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality
por: Mozaffari, Essy, et al.
Publicado: (2021)

506. Resistance Analyses from the Remdesivir Phase 3 REDPINE Study in Participants with Severely Reduced Kidney Function Who Were Hospitalized for COVID-19
por: Andreatta, Kristen, et al.
Publicado: (2023)

544. Using Active Surveillance to Identify Monoclonal Antibody Candidates Among COVID-19 Positive Veterans, Atlanta VA Healthcare System
por: Paras, Alexander T, et al.
Publicado: (2021)

1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans
por: Jeyapalina, Sujee, et al.
Publicado: (2022)

541. The Effect of Early Remdesivir Administration in COVID-19 Disease Progression
por: Platzer, Moritz, et al.
Publicado: (2023)

448. Real World Evaluation of Clinical Outcomes for Short-Duration Remdesivir Therapy in Hospitalized Patients with Mild-Moderate COVID-19
por: Williams, Kelsey N, et al.
Publicado: (2023)

545. Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants
por: Rodriguez, Lauren, et al.
Publicado: (2023)

Automated Design of Diverse Stand-Alone Riboswitches
por: Wu, Michelle J., et al.
Publicado: (2019)

Preludes and fugues BWV 544, 541, 546, 542 and 536
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1992)

Bactericidal Effect of Silver Nanoparticles on Intramacrophage Brucella abortus 544
por: Alizadeh, Hamed, et al.
Publicado: (2014)

Draft Genome Sequence of Brucella abortus Virulent Strain 544
por: Singh, D. K., et al.
Publicado: (2015)

SUN-544 A Not-So-Poetic Case of Abdominal Distension
por: Ellard, Karolina, et al.
Publicado: (2019)

544 Creating Communities for Burn Survivors Using Metaverse Platform
por: Hwang, Se-Hee
Publicado: (2023)

536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
por: Raffi, François, et al.
Publicado: (2021)

Locking Stand-Alone Cage Constructs for the Treatment of Cervical Spine Degenerative Disease
por: De Leo–Vargas, Roberto Alfonso, et al.
Publicado: (2019)

An MC68000 stand-alone CAMAC microprocessor system
por: Rijllart, A
Publicado: (1982)

Stand-Alone Cages for Anterior Cervical Fusion: Are There No Problems?
por: Han, Sang Youp, et al.
Publicado: (2016)

Stand-Alone and Hybrid Positioning Using Asynchronous Pseudolites
por: Gioia, Ciro, et al.
Publicado: (2014)

474. Real-World Experience of the Comparative Effectiveness and Safety of Remdesivir and Combination Therapy (Remdesivir and Monoclonal Antibodies) in Immunosuppressed Patients with Mild to Moderate COVID-19: A Retrospective Single-center Study in a Community Setting
por: Hirai, Jun, et al.
Publicado: (2023)

524. Hepatic Safety of Remdesivir Across Phase 3 Placebo-controlled COVID-19 Studies
por: Force, Lindsey, et al.
Publicado: (2023)

1360. Remdesivir in COVID 19 patients with kidney disease: A study on the renal function and outcomes
por: Barez, Marie Yvette, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5gkigdhnje9ksnlujfh2rh9for